We are building a novel cell manufacturing platform to enable stem cells to be maintained and differentiated, without any recombinant proteins in the feedstock. Recombinant proteins are by far the most expensive component of growing any cell type at scale. Within 1 year, we will reach a 26-fold reduction in media costs (21-fold reduction in total cost). Within 2 years, we will reach a 106-fold reduction in media costs (85-fold reduction in total cost). This technology will enable industry-leading cost per kg cell production.